 |
News
Partager cet article:
SAVE THE DATES !
12th International Symposium on Advances in Alzheimer Therapy
May 9-12, 2012 — Stockholm, Sweden
The meeting will focus on new targets and drugs for the treatment of Alzheimerʼs disease. The worldʼs leaders in the field will discuss new trial designs, animal models, neuroimaging including PET and diagnostic recommendations as well as CSF and blood markers. Emerging Novel Therapeutic Targets will be presented and a session on oral communications will be open to young scientists. We expect approximately 1500 participants, mostly neurologists, psychiatrists, geriatricians and pharmacologists.
Topics:
Drug Discovery and Treatment Development
New Preclinical Models of AD
Clinical Trials on AD: New Designs and Measures
Advances in Early Diagnosis of AD: Brain Imaging and Biomarkers
Emerging Novel Therapeutic Targets
Preventive Trials of AD
Active and Passive Immunization
Tau Pathology and Tau-Focused Therapy
What's New in Cholinergic Drugs? For more information, see flyer and visit www.ad-springfield.com Organizers: Ezio Giacobini, Gabriel Gold and Agneta Nordberg
Coordinators: Ann Hamilton (USA); Christine Mesmer (Europe)
Sponsors: Southern Illinois University School of Medicine, Springfield, Illinois, USA; University of Geneva Medical School, Geneva, Switzerland; Geneva University Hospitals, Department of Internal Medicine, Rehabilitation and Geriatrics, Geneva, Switzerland
|
|
